In conclusion, our results suggests that inhibiting production of lactadherin could reduce the risk for coronary atherosclerosis substantially and thus present MFGE8 as a potential therapeutical target for atherosclerotic cardiovascular disease. The gene discussed is MFGE8; the disease is coronary atherosclerosis.